Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-03SPRY144RICHARD LOWENTHAL plan to sell securities of ARS PHARMACEUTICALS, INC. under Form 144MEDIUM
RICHARD LOWENTHAL filed Form 144 to notify SEC of plan to sell 19805 units of ARS PHARMACEUTICALS, INC. securities around 2026-09-03, with aggregate market value of $115,564.16. The total outstanding units is 99447343.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in p...
Small CapBiotechnology
2026-09-03AXSM144Mark Jacobson plan to sell securities of Axsome Therapeutics, Inc. under Form 144MEDIUM
Mark Jacobson filed Form 144 to notify SEC of plan to sell 10000 units of Axsome Therapeutics, Inc. securities around 2026-09-03, with aggregate market value of $2,083,500.00. The total outstanding units is 52380818.0. The amount planned to be sold represents 0.02% of total outstanding units; ...
Large CapBiotechnology